The Indianapolis Star
By Jeff Swiatek
The top-selling drug at Eli Lilly and Co. came under renewed attack Monday, as Mississippi became the fifth state to sue the Indianapolis drug maker over its antipsychotic Zyprexa.
Mississippi’s activist attorney general, Jim Hood, who has a reputation for suing companies on behalf of consumers in high-profile issues, charged that Lilly promoted Zyprexa for unapproved uses, including for children.
The lawsuit by Hood seeks repayment from Lilly for more than $100 million that the state’s Medicaid program for the poor has paid for the drug, plus reimbursement for diabetes-related injuries the drug caused some Medicaid users…
Atypical Antipsychotics 